ZYBT (Zhengye Biotechnology Holding Limited Class A Ordinary Shares) Stock Analysis - Insider Trades

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) is a publicly traded Healthcare sector company. As of May 21, 2026, ZYBT trades at $0.88 with a market cap of $43.74M and a P/E ratio of 0.00. ZYBT moved +0.00% today. Year to date, ZYBT is -22.78%; over the trailing twelve months it is -88.54%. Its 52-week range spans $0.68 to $14.30. Rallies surfaces ZYBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ZYBT stock inside the company?

Rallies tracks ZYBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

ZYBT Key Metrics

Key financial metrics for ZYBT
MetricValue
Price$0.88
Market Cap$43.74M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$14.30
52-Week Low$0.68
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ZYBT News

ZYBT Analyst Consensus

ZYBT analyst coverage data. Average price target: $0.00.

Common questions about ZYBT

Who is trading ZYBT stock inside the company?
Rallies tracks ZYBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for ZYBT?
Yes. Rallies tracks ZYBT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ZYBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ZYBT. It does not provide personalized investment advice.
ZYBT

ZYBT